title: Mechanism-based engineering against anthracycline cardiotoxicity.
authors.forename: Thomas
authors.initials: T
authors.lastname: Force
authors.forename: Yibin
authors.initials: Y
authors.lastname: Wang
mesh_terms: D000818:Animals; D002316:Cardiotonic Agents / Q000494:pharmacology*; D002616:Chemical Engineering / Q000379:methods*; D004317:Doxorubicin / Q000633:toxicity*; D005260:Female; D006801:Humans; D008297:Male; D032383:Myocytes, Cardiac / Q000187:drug effects*; D020890:Neuregulin-1 / Q000235:genetics* / Q000494:pharmacology*
chemical_list: D002316:Cardiotonic Agents; D020890:Neuregulin-1; C117467:neuregulin beta; D004317:Doxorubicin
keywords: DNA topoisomerases, type II; Editorials; doxorubicine; ligands; neoplasms; neuregulin-beta; stroke